profits slide at india's dr reddy profits at indian drugmaker dr reddy's fell 93% as research costs rose and sales flagged. patents on a number of well known products are due to run out in the near future, representing an opportunity for dr reddy, whose shares are listed in new york, and other indian generics manufacturers.